BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23828693)

  • 1. Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.
    Zhou F; Xu J; Ding G; Cao L
    Pathol Oncol Res; 2014 Jan; 20(1):73-9. PubMed ID: 23828693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of pGSK-3α/β Tyr279/216 and XIAP proteins in cholangiocarcinoma and their clinical significance].
    Xu JW; Zhou F; Jiang GX; Chen CY; Wang JJ; Cao LP
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):366-71. PubMed ID: 24054014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma.
    Lin KY; Fang CL; Chen Y; Li CF; Chen SH; Kuo CY; Tai C; Uen YH
    Ann Surg Oncol; 2010 Jun; 17(6):1695-702. PubMed ID: 20087779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
    Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
    Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
    J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma.
    Yeh CN; Chen MH; Chang YC; Wu RC; Tsao LC; Wang SY; Cheng CT; Chiang KC; Chen TW; Hsiao M; Weng WH
    Mol Carcinog; 2019 Feb; 58(2):270-278. PubMed ID: 30334579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.
    Palumbo T; Poultsides GA; Kouraklis G; Liakakos T; Drakaki A; Peros G; Hatziapostolou M; Iliopoulos D
    BMC Cancer; 2016 Jun; 16():353. PubMed ID: 27259577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.